Prophylactic and Preemptive Therapy with Dasatinib after Hematopoietic Stem Cell Transplantation for Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia

被引：52
作者：
Caocci, Giovanni [1 ]
Vacca, Adriana [1 ]
Ledda, Antonio [1 ]
Murgia, Francesca [1 ]
Piras, Eugenia [1 ]
Greco, Marianna [1 ]
Arras, Marcella [1 ]
Atzeni, Sandra [1 ]
Littera, Roberto [1 ]
La Nasa, Giorgio [1 ]
机构：
[1] Univ Cagliari, Hematol Unit, Dept Internist Med Sci, I-09124 Cagliari, Italy
来源：
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION | 2012年 / 18卷 / 04期
关键词：
IMATINIB; CHEMOTHERAPY; INHIBITORS;
D O I：
10.1016/j.bbmt.2011.12.587
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：652 / 654
页数：3
相关论文
共 12 条
  • [1] Re: Imatinib mesylate administration in the first 100 days after stem cell transplantation
    Anderlini, P
    Sheth, S
    Hicks, K
    Ippoliti, C
    Giralt, S
    Champlin, RE
    [J]. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2004, 10 (12) : 883 - 884
  • [2] Dasatinib as first-line treatment for adult patients with Philadelphia chromosome-positive acute lymphoblastic leukemia
    Foa, Robin
    Vitale, Antonella
    Vignetti, Marco
    Meloni, Giovanna
    Guarini, Anna
    De Propris, Maria Stefania
    Elia, Loredana
    Paoloni, Francesca
    Fazi, Paola
    Cimino, Giuseppe
    Nobile, Francesco
    Ferrara, Felicetto
    Castagnola, Carlo
    Sica, Simona
    Leoni, Pietro
    Zuffa, Eliana
    Fozza, Claudio
    Luppi, Mario
    Candoni, Anna
    Iacobucci, Ilaria
    Soverini, Simona
    Mandelli, Franco
    Martinelli, Giovanni
    Baccarani, Michele
    [J]. BLOOD, 2011, 118 (25) : 6521 - 6528
  • [3] Long-Term Follow-up of Allogeneic Hematopoietic Stem Cell Transplantation for Patients with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: Impact of Tyrosine Kinase Inhibitors on Treatment Outcomes
    Kebriaei, Partow
    Saliba, Rima
    Rondon, Gabriela
    Chiattone, Alexandre
    Luthra, Rajyalakshmi
    Anderlini, Paolo
    Andersson, Borje
    Shpall, Elizabeth
    Popat, Uday
    Jones, Roy
    Worth, Laura
    Ravandi, Farhad
    Thomas, Deborah
    O'Brien, Susan
    Kantarjian, Hagop
    de Lima, Marcos
    Giralt, Sergio
    Champlin, Richard
    [J]. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2012, 18 (04) : 584 - 592
  • [4] Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia Current Treatment and Future Perspectives
    Lee, Hun J.
    Thompson, James E.
    Wang, Eunice S.
    Wetzler, Meir
    [J]. CANCER, 2011, 117 (08) : 1583 - 1594
  • [5] Clinical effect of imatinib added to intensive combination chemotherapy for newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia
    Lee, KH
    Lee, JH
    Choi, SJ
    Lee, JH
    Seol, M
    Lee, YS
    Kim, WK
    Lee, JS
    Seo, EJ
    Jang, S
    Park, CJ
    Chi, HS
    [J]. LEUKEMIA, 2005, 19 (09) : 1509 - 1516
  • [6] Role of Tyrosine Kinase Inhibitors in the Management of Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia
    Mathisen, Michael S.
    O'Brien, Susan
    Thomas, Deborah
    Cortes, Jorge
    Kantarjian, Hagop
    Ravandi, Farhad
    [J]. CURRENT HEMATOLOGIC MALIGNANCY REPORTS, 2011, 6 (03) : 187 - 194
  • [7] In vitro activity of Bcr-Abl inhibitors AMN107 and BMS-354825 against clinically relevant imatinib-resistant Abl kinase domain mutants
    O'Hare, T
    Walters, DK
    Stoffregen, EP
    Jia, TP
    Manley, PW
    Mestan, J
    Cowan-Jacob, SW
    Lee, FY
    Heinrich, MC
    Deininger, MWN
    Druker, BJ
    [J]. CANCER RESEARCH, 2005, 65 (11) : 4500 - 4505
  • [8] First report of phase 2 study of dasatinib with hyper-CVAD for the frontline treatment of patients with Philadelphia chromosome-positive (Ph+) acute lymphoblastic leukemia
    Ravandi, Farhad
    O'Brien, Susan
    Thomas, Deborah
    Faderl, Stefan
    Jones, Dan
    Garris, Rebecca
    Dara, Samuel
    Jorgensen, Jeffrey
    Kebriaei, Partow
    Champlin, Richard
    Borthakur, Gautam
    Burger, Jan
    Ferrajoli, Alessandra
    Garcia-Manero, Guillermo
    Wierda, William
    Cortes, Jorge
    Kantarjian, Hagop
    [J]. BLOOD, 2010, 116 (12) : 2070 - 2077
  • [9] Concurrent intensive chemotherapy and imatinib before and after stem cell transplantation in newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia. Final resullts of the CSTIBES02 trial
    Ribera, Josep-Maria
    Oriol, Albert
    Gonzalez, Marcos
    Vidriales, Belen
    Brunet, Salut
    Esteve, Jordi
    del Potro, Eloy
    Rivas, Concepcion
    Moreno, Maria-Jose
    Tormo, Mar
    Martin-Reina, Victoria
    Sarra, Josep
    Parody, Ricardo
    Perez de Oteyza, Jaime
    Bureo, Encarna
    Bernal, Maria-Teresa
    [J]. HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 (01): : 87 - 95
  • [10] Imatinib plus steroids induces complete remissions and prolonged survival in elderly Philadelphia chromosome-positive patients with acute lymphoblastic leukemia without additional chemotherapy:: results of the Gruppo Italiano Malattie Ematologiche dell'Adulto (GIMEMA) LAL0201-B protocol
    Vignetti, Marco
    Fazi, Paola
    Cimino, Giuseppe
    Martinelli, Giovanni
    Di Raimondo, Francesco
    Ferrara, Felicetto
    Meloni, Giovanna
    Ambrosetti, Achille
    Quarta, Giovanni
    Pagano, Livio
    Rege-Cambrin, Giovanna
    Elia, Loredana
    Bertieri, Raffaello
    Annino, Luciana
    Foa, Robin
    Baccarani, Michele
    Mandelli, Franco
    [J]. BLOOD, 2007, 109 (09) : 3676 - 3678
12